TGDIX | VIVAX | TGDIX / VIVAX | |
Total Expense Ratio | 0.70 | 0.17 | 412% |
Annual Report Gross Expense Ratio | 0.77 | 0.17 | 453% |
Fund Existence | 22 years | 33 years | - |
Gain YTD | 7.138 | 5.103 | 140% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 3000 | 67% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 464M | 195B | 0% |
Annual Yield % from dividends | 0.73 | 2.06 | 36% |
Returns for 1 year | 5.78 | 6.23 | 93% |
Returns for 3 years | 39.69 | 35.73 | 111% |
Returns for 5 years | 64.43 | 71.88 | 90% |
Returns for 10 years | -20.04 | 109.38 | -18% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ORCX | 35.99 | 2.19 | +6.48% |
Defiance Daily Target 2X Long ORCL ETF | |||
ITDB | 31.50 | 0.13 | +0.40% |
iShares LifePath Target Date 2030 ETF | |||
XBI | 88.12 | 0.30 | +0.34% |
SPDR® S&P Biotech ETF | |||
BBBS | 51.17 | 0.03 | +0.06% |
BondBloxx BBB Rated 1-5 Yr Corp Bd ETF | |||
EYLD | 36.61 | 0.01 | +0.03% |
Cambria Emerging Shareholder Yield ETF |